TG Therapeutics announces second quarter 2014 financial results
TG Therapeutics reported the consolidated net loss for the 2014 second quarter was $12.0 million versus a consolidated net loss of $6.6 million during the comparable 2013 quarter. At June 30, 2014 the Company had cash, and equivalents of $51.2 million. July 22, 2014